Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Disclosure of cardiac variants of uncertain significance results in an exome cohort
View through CrossRef
This study examined the impact of disclosing subclassifications of genetic variants of uncertain significance (VUS) on behavioral intentions. We studied return of VUS results to 79 individuals with a cardiomyopathy‐associated VUS, subclassified into VUS‐high or VUS‐low. Primary outcomes were perceived risk (absolute and comparative), perceived severity, perceived value of information, self‐efficacy, decision regret, and behavioral intentions to share results and change behaviors. There was no significant difference between the 2 subclasses in overall behavioral intentions (
t
= 0.023,
P
= .982) and each of the individual items on the behavioral intentions scale; absolute (
t
= −1.138,
P
= .259) or comparative (
t
= −0.463,
P
= .645) risk perceptions; perceived value of information (
t
= 0.582,
P
= .563) and self‐efficacy (
t
= −0.733,
P
= .466). Decision regret was significantly different (
t
= 2.148,
P
= .035), with VUS‐low (mean = 17.24, SD = 16.08) reporting greater regret. Combining the subclasses, perceived value of information was the strongest predictor of behavioral intentions (
β
= 0.524,
P
< .001). Participants generally understood the meaning of a genetic VUS result classification and reported satisfaction with result disclosure. No differences in behavioral intentions were found, but differences in decision regret suggest participants distinguish subclasses of VUS results. The perceived value of VUS may motivate recipients to pursue health‐related behaviors.
Title: Disclosure of cardiac variants of uncertain significance results in an exome cohort
Description:
This study examined the impact of disclosing subclassifications of genetic variants of uncertain significance (VUS) on behavioral intentions.
We studied return of VUS results to 79 individuals with a cardiomyopathy‐associated VUS, subclassified into VUS‐high or VUS‐low.
Primary outcomes were perceived risk (absolute and comparative), perceived severity, perceived value of information, self‐efficacy, decision regret, and behavioral intentions to share results and change behaviors.
There was no significant difference between the 2 subclasses in overall behavioral intentions (
t
= 0.
023,
P
= .
982) and each of the individual items on the behavioral intentions scale; absolute (
t
= −1.
138,
P
= .
259) or comparative (
t
= −0.
463,
P
= .
645) risk perceptions; perceived value of information (
t
= 0.
582,
P
= .
563) and self‐efficacy (
t
= −0.
733,
P
= .
466).
Decision regret was significantly different (
t
= 2.
148,
P
= .
035), with VUS‐low (mean = 17.
24, SD = 16.
08) reporting greater regret.
Combining the subclasses, perceived value of information was the strongest predictor of behavioral intentions (
β
= 0.
524,
P
< .
001).
Participants generally understood the meaning of a genetic VUS result classification and reported satisfaction with result disclosure.
No differences in behavioral intentions were found, but differences in decision regret suggest participants distinguish subclasses of VUS results.
The perceived value of VUS may motivate recipients to pursue health‐related behaviors.
Related Results
Cohort studies
Cohort studies
A cohort study is one in which the outcome (usually disease status) is ascertained for groups of individuals defined on the basis of their exposure. At the time exposure status is ...
Pilarowski–Bjornsson Syndrome with Congenital Heart Defect: A Case Report and Literature Review
Pilarowski–Bjornsson Syndrome with Congenital Heart Defect: A Case Report and Literature Review
Abstract
Introduction
Pilarowski–Bjornsson syndrome (PILBOS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous variants in chromodomain helicase DNA-b...
Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism
Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism
Abstract
Introduction: Venous thromboembolism (VTE), defined as deep venous thrombosis (DVT) and pulmonary embolism (PE), is a cause of significant morbidity and mor...
Cardiac Myxoma Post-Transseptal Ablation: Coincidence or Causation?
Cardiac Myxoma Post-Transseptal Ablation: Coincidence or Causation?
Background: Cardiac myxomas are benign cardiac neoplasms usually found solitarily located within a single cardiac chamber, most commonly in the left atrium. With no established cau...
Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care
Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care
PURPOSE Genetic testing has clinical utility in the management of patients with hereditary cancer syndromes. However, the increased likelihood of encountering a variant of uncertai...
Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing
Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing
Key Points
MUC1 is associated with autosomal dominant tubulointerstitial kidney disease, a ...
Abstract 2094: Comparing exome with whole-genome next-generation sequencing in detecting somatic mutations
Abstract 2094: Comparing exome with whole-genome next-generation sequencing in detecting somatic mutations
Abstract
Exome sequencing has been used as an efficient and cost-effective method of identifying somatic mutations in tumors. In order to evaluate the effectiveness ...
Agency Costs, Information and Portfolio Disclosure by Mutual Funds
Agency Costs, Information and Portfolio Disclosure by Mutual Funds
In response to the alleged trading and marketing abuses in the mutual fund industry, the SEC recently adopted a new rule requiring more frequent portfolio disclosure in order to re...